The Red Herring yesterday published analysis of the business of AIDS vaccines, highlighting the limited public sector funding growth is turning attention to the private sector. Under current circumstances, the private sector has limited motivation to participate. Seth Berkley of IAVI comments:
"In terms of small biotech companies, it would be a death knell for them to go to their investors and say 'Hey we're investing massively in an HIV vaccine'"
The solution, according to Berkley and others, is to create incentives for AIDS research, including prizes, tax credits, or advance purchase commitments such as those proposed to be addressed at the July G8 meeting.
Topics
DISCLAIMER & PERMISSIONS
CGD's publications reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions. You may use and disseminate CGD's publications under these conditions.
